Our results suggest that ALDH activity partially mediated by the ALDH1A3 isoform in HNSCC cells may be correlated with radiotherapy outcome depending on its activation level during therapy. This evidence concerns the gene ALDH1A3 and head and neck squamous cell carcinoma.